Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Transplant Rev (Orlando). 2014 Mar 4;29(1):23–32. doi: 10.1016/j.trre.2014.01.002

Fig. 5.

Fig. 5

Potential applications of miRNAs as biomarkers in different conditions involved in graft function in liver transplantation. The liver transplantation model is used in the present figure to show the most important applications of miRNAs as biomarkers. The miRNAs included in the figure are the result of several publications and have been found to behave as disease-associated markers. This figure depicts the many opportunities for evaluating these markers (e.g. conditions likeAR [with or without HCV] have not yet been evaluated). Moreover, most of these results lack mechanistic studies exploring the role of the miRNAs in the disease. Copyright © 2012 Kilian Weigand et al [4]; Open access article distributed under the Creative Commons Attribution License.